We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

5 hedge funds and large institutions have $546K invested in Innovator IBD ETF Leaders ETF in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 45 (+1)

3% more capital invested

Capital invested by funds: $531K → $546K (+$15K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$23
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$406K -$53.2K -2,288 -12%
UBS Group
2
UBS Group
Switzerland
$58K -$17.4K -747 -24%
Osaic Holdings
3
Osaic Holdings
Arizona
$58K -$11.6K -500 -17%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$24K
Wells Fargo
5
Wells Fargo
California
+$23 +1 New

LDRS Hedge Fund Activity: Q3 2020 in Review

5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q3 2020, worth a combined $546K — up 2.8% from $531K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LDRS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Wells Fargo, opening a new position worth an estimated $23. The largest seller was Citadel Advisors, cutting an estimated $53.2K.

  • 5 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q3 2020, up from 4 in Q2 2020.
  • Funds reported $546K of Innovator IBD ETF Leaders ETF stock for Q3 2020, up 2.8% quarter-over-quarter.
  • 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q3 2020 and 0 closed out, a net change of +1 holder.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q3 2020 was Wells Fargo, an estimated $23 added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q3 2020 was Citadel Advisors, an estimated $53.2K sold.

Based on aggregated 13F filings for Q3 2020.